NR2E3 and retinitis pigmentosa 1: As a result, inhibiting the Nr2e3 and Rho pathways has been suggested as a potential neuroprotective strategy to treat RP (Moore et al., 2020), and may also underlie a therapeutic mechanism through which TES exerts its benefits.